Table 1.

Effect of kaempferol-3-O-alpha-L-rhamnoside on viable Ehrlich ascites carcinoma (EAC) cell growth

Group	Treatment	Viable EAC cells on day 7 after inoculation (× 107 cells/ml)	Percentage (%) cell growth inhibition
1	EAC Cell	7.51 ± 0.83
2	EAC + Sz-02 (50 mg/kg)	2.16 ± 0.38*	70.89 ± 6.62*
3	EAC + Sz-02 (25 mg/kg)	4.674 ± 0.28*	37.17 ± 7.94*
4	Vincristine (6.25 mg/kg)	1.64 ± 0.51*	77.84 ± 6.89*

Data are expressed as mean ± SD (n = 5); Analysis of variance followed by LSD and Dunnett’t post hoc test (IBM-SPSS/20)

^*P < 0.05: Significance difference with respect to EAC control